NPCE logo

NeuroPace Stock Price

Symbol: NasdaqGM:NPCEMarket Cap: US$287.3mCategory: Healthcare

NPCE Share Price Performance

NPCE Community Fair Values

Recent NPCE News & Updates

No updates

NeuroPace, Inc. Key Details

US$84.3m

Revenue

US$21.2m

Cost of Revenue

US$63.1m

Gross Profit

US$87.9m

Other Expenses

-US$24.8m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 12, 2025
Earnings per share (EPS)
-0.76
Gross Margin
74.83%
Net Profit Margin
-29.42%
Debt/Equity Ratio
246.4%

NeuroPace, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About NPCE

Founded
1997
Employees
195
CEO
Joel Becker
WebsiteView website
www.neuropace.com

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

U.S. Market Performance

  • 7 Days: -0.6%
  • 3 Months: 11.8%
  • 1 Year: 16.8%
  • Year to Date: 7.5%
In the last week, the market has been flat, with a notable exception in the Healthcare sector dropping 4.2%. More promisingly, the market is up 17% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading